Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brad Spellberg

Showing results (121-130 of 267) with videos related to

Pageof 27
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 7, 2024
ESR and CRP: it is time to stop the zombie tests: author's responseBrad Spellberg, Bassam Ghanem, Tom Boyles, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 19, 2021
Should Therapeutic Drug Monitoring Based on the Vancomycin Area Under the Concentration-Time Curve Be Standard for Serious Methicillin-Resistant Staphylococcus aureus Infections?-NoSarah C J Jorgensen, Brad Spellberg, Andrew F Shorr, et al.
The American Journal of Medicine|June 25, 2013
Capturing the diagnosis: an internal medicine education program to improve documentationBrad Spellberg, Darrell Harrington, Susan Black, et al.
Plos One|September 9, 2025
Evaluating antibody mediated opsonophagocytosis of bacteria via lab protocol: RAW 264.7 cell phagocytosis assayMatthew Slarve, Travis Nielsen, Dongran Yu, et al.
The Journal of Antimicrobial Chemotherapy|November 28, 2009
The iron chelator deferasirox enhances liposomal amphotericin B efficacy in treating murine invasive pulmonary aspergillosisAshraf S Ibrahim, Teclegiorgis Gebremariam, Samuel W French, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 14, 2009
Recent advances in the management of mucormycosis: from bench to bedsideBrad Spellberg, Thomas J Walsh, Dimitrios P Kontoyiannis, et al.
FEMS Immunology and Medical Microbiology|January 23, 2009
Immunological surrogate marker of rAls3p-N vaccine-induced protection against Staphylococcus aureusLin Lin, Ashraf S Ibrahim, Beverlie Baquir, et al.
Open Forum Infectious Diseases|November 18, 2020
Pharmacology, Dosing, and Side Effects of Rifabutin as a Possible Therapy for Antibiotic-Resistant <i>Acinetobacter</i> InfectionsMatthew C Phillips, Noah Wald-Dickler, Katherine Loomis, et al.
Antimicrobial Agents and Chemotherapy|October 22, 2008
Posaconazole mono- or combination therapy for treatment of murine zygomycosisAshraf S Ibrahim, Teclegiorgis Gebremariam, Julie A Schwartz, et al.
BMC Microbiology|November 4, 2015
Cryopreservation of virulent Acinetobacter baumannii to reduce variability of in vivo studiesTravis B Nielsen, Kevin W Bruhn, Paul Pantapalangkoor, et al.
Pageof 27

Showing results (121-130 of 267) with videos related to

Sort By:
Pageof 27
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 7, 2024
ESR and CRP: it is time to stop the zombie tests: author's responseBrad Spellberg, Bassam Ghanem, Tom Boyles, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 19, 2021
Should Therapeutic Drug Monitoring Based on the Vancomycin Area Under the Concentration-Time Curve Be Standard for Serious Methicillin-Resistant Staphylococcus aureus Infections?-NoSarah C J Jorgensen, Brad Spellberg, Andrew F Shorr, et al.
The American Journal of Medicine|June 25, 2013
Capturing the diagnosis: an internal medicine education program to improve documentationBrad Spellberg, Darrell Harrington, Susan Black, et al.
Plos One|September 9, 2025
Evaluating antibody mediated opsonophagocytosis of bacteria via lab protocol: RAW 264.7 cell phagocytosis assayMatthew Slarve, Travis Nielsen, Dongran Yu, et al.
The Journal of Antimicrobial Chemotherapy|November 28, 2009
The iron chelator deferasirox enhances liposomal amphotericin B efficacy in treating murine invasive pulmonary aspergillosisAshraf S Ibrahim, Teclegiorgis Gebremariam, Samuel W French, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 14, 2009
Recent advances in the management of mucormycosis: from bench to bedsideBrad Spellberg, Thomas J Walsh, Dimitrios P Kontoyiannis, et al.
FEMS Immunology and Medical Microbiology|January 23, 2009
Immunological surrogate marker of rAls3p-N vaccine-induced protection against Staphylococcus aureusLin Lin, Ashraf S Ibrahim, Beverlie Baquir, et al.
Open Forum Infectious Diseases|November 18, 2020
Pharmacology, Dosing, and Side Effects of Rifabutin as a Possible Therapy for Antibiotic-Resistant <i>Acinetobacter</i> InfectionsMatthew C Phillips, Noah Wald-Dickler, Katherine Loomis, et al.
Antimicrobial Agents and Chemotherapy|October 22, 2008
Posaconazole mono- or combination therapy for treatment of murine zygomycosisAshraf S Ibrahim, Teclegiorgis Gebremariam, Julie A Schwartz, et al.
BMC Microbiology|November 4, 2015
Cryopreservation of virulent Acinetobacter baumannii to reduce variability of in vivo studiesTravis B Nielsen, Kevin W Bruhn, Paul Pantapalangkoor, et al.
Pageof 27